LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    What if we used algae to make biofuel?

    20/01/2020
    FACTSHEET
    What if we used algae to make biofuel?

    Will we be trading barrels of algae instead of oil in the future?

    Solution: Adjusting a specific algae gene with genome editing, enabling the algae to be a feedstock for biofuels.

    Did you know?
    Average global oil consumption was 93 million barrels per day in 2015. Algal biofuel could help substitute this, thereby contributing to the 7th UN Sustainable Development Goal of Affordable and Clean Energy.

    Scientists have been trying to make algal fuels commercially viable since the 70’s, continuously hitting the same limitation: algae are capable of either rapid growth or high lipid (oil) production, but not both. So, while large-scale production of biofuel was possible, this trade-off meant it would not be competitive with fossil fuels.

    However, in 2017, researchers from Synthetic Genomics and ExxonMobil managed to overcome the problem. Their first step was a global algae-hunt to find the most suitable algae species, which they found to be Nannochloropsis. Then, the researchers set about sequencing the strain’s 9000 genes and identified 20 potential “master regulators” of lipid production. The regulators were made inactive one-by-one by using CRISPR genome editing. This technique allows scientists to make changes to the individual letters of the genetic code in an efficient and easy way. One of the 20 regulators, the ZynCys gene, dramatically increased lipid production when knocked out, but also stunted growth. However, by adjusting the gene’s activity with another tool, called RNA interference, the normal growth rate was retained while also doubling the lipid production. The trade-off was overcome.

    Today, the research has moved outdoors to field studies in contained ponds. This will provide a better understanding of the fundamental engineering parameters, enabling the scaling of the technology for potential commercial deployment. To demonstrate their belief in the project’s potential, the companies have recently set the goal of producing 10.000 barrels of algae biofuel per day by 2025. A welcome ambition and a good start for cutting down on oil consumption.

    What if we used algae to make biofuel?


    Download
    2020_01_I_F_EuropaBIO_WHATIF_biofuel_V02Download
    Share
    Communications Team
    Communications Team

    Related posts

    06/03/2026

    Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe


    Read more
    06/02/2026

    OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States


    Read more
    03/02/2026

    Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe


    Read more

    Important links

    • Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe
    • The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.